Rosen Law Firm Encourages Neumora Therapeutics, Inc. Investors to File Securities Class Action Suit Before Important Deadline

Friday 28th of March 2025 22:02:00

NMRA Important Deadline: Rosen Skilled Investor Counsel Encourages Neumora Therapeutics Inc. (NMRA) Investors to File Securities Class Action Lawsuit

March 25, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of Neumora Therapeutics Inc. (NASDAQ: NMRA) securities between April 14, 2022 and March 15, 2023, of the important April 14, 2023 lead plaintiff deadline in the securities class action lawsuit filed by the firm on behalf of investors who purchased Neumora securities during the class period.

The lawsuit alleges that Neumora and certain of its officers and directors made false and misleading statements to the market, violating federal securities laws. Specifically, the complaint alleges that Neumora's statements about its business, operations, and prospects were materially false and misleading, and that the company's failure to disclose the true nature of its business and the risks associated with its operations caused significant harm to investors.

On March 15, 2023, the stock price of Neumora plummeted after the company announced that it would be discontinuing its lead product candidate, NM-911, due to disappointing clinical trial results.

A class action lawsuit has been filed on behalf of all those who purchased Neumora securities during the class period. The lawsuit seeks to recover damages for Neumora investors under the federal securities laws.

If you purchased Neumora securities during the class period and would like to join the action, please contact Rosen Law Firm's Chief Compliance Officer, Kevin Park, at kpark@rosen.com or 866-767-3653.

A lead plaintiff is a representative party that acts on behalf of all parties involved. If you are a current or former Neumora investor and would like to learn more about the lawsuit, please contact Rosen Law Firm's Chief Compliance Officer, Kevin Park, at kpark@rosen.com or 866-767-3653. You can also visit our website at www.rosen.com to learn more about the lawsuit. The Rosen Law Firm represents investors worldwide, focusing on securities law violations. If you experienced a loss, you might have valuable claims. Contact us to learn more. Certain information contained in this notice is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. This notice is not an offer to sell or buy any security. By your use of this website, you are agreeing to the terms and conditions that govern the use of this website. Please read these terms and conditions carefully before using the website.